RxDoctor Payments Data

Stuart Lebas, MD

Critical Care Medicine · Baton Rouge, LANPI 1073518510

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $487 and has fallen 95.7% since, to $21 in 2025. That places this record below the midpoint for critical care medicine clinicians in LA, where the typical reported total is $950.

$647in general payments, 2019–2025

Across 36 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$126
  • GSK$84
  • Edwards Lifesciences$83
  • AstraZeneca$72
  • Regeneron Healthcare Solutions, Inc.$47
  • Paratek Pharmaceuticals, Inc.$42
  • plus $195 from 9 others

What the payments were for

  • Food & beverage$647100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$647 in reported general payments places this provider in the 45th percentile of 72 critical care medicine providers in Louisiana.

See all critical care medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$10,122
Medicare patients
37
Services billed
103

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →